Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-02

FDA Approved: POLYETHYLENE GLYCOL (3350) — Supplemental Application (Mylan Institutional Inc.)

View source ↗

Summary

The FDA approved a supplemental application for polyethylene glycol 3350 submitted by Mylan Institutional Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene glycol 3350 (polyethylene glycol 3350)

Snippet

SUPPL AP for POLYETHYLENE GLYCOL (3350) (POLYETHYLENE GLYCOL (3350))